|
Xenobiotic-Metabolizing Enzymes
|
ZIA BC 005562
|
$679,493
|
$509,619
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
ZIA BC 005708
|
$849,366
|
$849,366
|
Gonzalez, Frank
|
CCR (NCI)
|
|
WUMC Cancer and Leukemia Group B
|
2U10CA077440-12
|
$345,040
|
$79,359
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Wound Angiogenesis as a Biomarker for Tumor Angiogenesis
|
5K24CA113755-04
|
$124,659
|
$124,659
|
HURWITZ, HERBERT
|
DUKE UNIVERSITY
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-08
|
$14,000
|
$2,100
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Wnt signaling in Colon Cancer
|
5R01CA108697-05
|
$274,978
|
$274,978
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
ZIA BC 011050
|
$55,899
|
$5,590
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Whole Genome Scan for Modifier Genes in Colorectal Cancer
|
5R01CA126895-02
|
$1,244,231
|
$1,244,231
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Vitamin D/Calcium and Oxidative Stress and Inflammation Biomarkers
|
1R03CA136113-01A1
|
$77,500
|
$77,500
|
BOSTICK, ROBERD
|
EMORY UNIVERSITY
|
|
VITamin D and omegA-3 triaL (VITAL)
|
1U01CA138962-01
|
$2,694,337
|
$538,867
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vitamin D and Colorectal Cancer
|
5R01CA122299-02
|
$345,845
|
$345,845
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Visualizing Immune Responses in vivo: a systems biology approach
|
1R21CA139168-01A1
|
$225,544
|
$225,544
|
Duda, Dan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-03
|
$1,060,761
|
$1,060,761
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$73,262
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
3R01CA131133-02S1
|
$21,954
|
$21,954
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
5R01CA131133-02
|
$267,258
|
$267,258
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
5R01CA056533-17
|
$423,750
|
$423,750
|
Schneider, Robert
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010183-00580
|
$94,490
|
$18,898
|
McGlynn
|
DCEG (NCI)
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
2R37CA050286-21
|
$468,441
|
$117,110
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
VDR Variants, Nutrient Intakes, and Adenoma Recurrence
|
5K07CA106269-05
|
$134,115
|
$134,115
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
|
VCU Minority-Based CCOP
|
3U10CA052784-19S1
|
$99,999
|
$19,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-19
|
$314,164
|
$59,691
|
Roberts, John
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Variations of calorie restriction for the prevention of pancreatic cancer
|
1R21CA127840-01A2
|
$203,940
|
$203,940
|
LANZA-JACOBY, SUSAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Variations in Colonoscopy Screening: A Population Based Study
|
5R01CA131141-02
|
$941,511
|
$941,511
|
Dietrich, Allen
|
DARTMOUTH COLLEGE
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-02
|
$1,500,000
|
$420,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIA BC 011175
|
$399,957
|
$399,957
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
VALIDATION AND QUANTIFICATION OF FFPE ANTIGEN RETRIEVAL BY PROTEOME ANALYSIS
|
5R42CA122715-04
|
$750,000
|
$375,000
|
SAXENA, SATYA
|
CALIBRANT BIOSYSTEMS, INC.
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
5R01CA132829-02
|
$396,689
|
$396,689
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$283,437
|
$28,344
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$330,677
|
$66,135
|
Hodge, James
|
CCR (NCI)
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
5U19CA113297-05
|
$1,038,617
|
$519,309
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Utilizing Glycosyltransferases for Bioconjugation
|
ZIA BC 010742
|
$187,047
|
$46,762
|
Qasba, Pradman
|
CCR (NCI)
|
|
Using the Allergic Immune System to Target Cancer
|
3K22CA111639-03S1
|
$10,667
|
$3,520
|
MOLLICK, JOSEPH
|
STANFORD UNIVERSITY
|
|
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer
|
5R01CA123277-03
|
$311,600
|
$311,600
|
BEDI, ATUL
|
JOHNS HOPKINS UNIVERSITY
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
2U01CA105492-06
|
$742,917
|
$245,163
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Using mouse knockouts to unravel endothelial gene function
|
ZIA BC 010736
|
$194,557
|
$19,456
|
St. Croix, Brad
|
CCR (NCI)
|
|
Using Mouse Endoscopy for Evaluating Colon Cancer
|
5R01CA125691-02
|
$340,525
|
$340,525
|
Rosenberg, Daniel
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Using Message Framing to Promote Physical Activity in Colorectal Cancer Survivors
|
5R21CA125458-02
|
$210,600
|
$210,600
|
JONES, LEE
|
DUKE UNIVERSITY
|
|
Using Ecolog. Momentary Assess. To Examine Pain & Smoking In Head & Neck Cancer P
|
1R03CA139914-01
|
$77,000
|
$77,000
|
Lam, Cho
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$647,637
|
$129,527
|
Keefer, Larry
|
CCR (NCI)
|
|
Use of Quantitative RT-PCR for Staging Esophageal Cancer
|
5R01CA090665-09
|
$271,168
|
$271,168
|
LUKETICH, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of 2-deoxy-D-glucose & PI3K/Akt pathway inhibitors in head & neck cancer ther
|
1K01CA134941-01A1
|
$109,080
|
$109,080
|
SIMONS, ANDREAN
|
UNIVERSITY OF IOWA
|
|
USC Center for Transdisciplinary Research on Energetics*
|
3U54CA116848-05S2
|
$62,600
|
$62,600
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Center for Transdisciplinary Research on Energetics*
|
3U54CA116848-05S3
|
$89,557
|
$89,557
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Center for Transdisciplinary Research on Energetics*
|
5U54CA116848-05
|
$2,256,107
|
$2,256,107
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urine Biomarker Discovery for Early Detection of Liver Cancer
|
5R01CA125642-02
|
$341,434
|
$341,434
|
SU, YING-HSIU
|
DREXEL UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$320,323
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
2U10CA037420-25
|
$1,533,879
|
$153,388
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
University of Maryland Biomarker Reference Laboratory
|
5U24CA115091-05
|
$410,998
|
$410,998
|
STASS, STANFORD
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Universal MUC1 Targeted Immunotherapy
|
1R43CA141738-01
|
$140,720
|
$70,360
|
ORENTAS, RIMAS
|
LENTIGEN CORPORATION
|
Total relevant funding to Digestive Diseases for this search: $450,822,745
|